Collegium Pharmaceutical Inc
COLL
Market Cap$962.02M
Close$
$17.40
41.1% downside
Current Fair Value
41.1% downsideOvervalued by 41.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $962.02 Million |
|---|---|
| Enterprise Value | $1.73 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $2.14 |
| Beta | 0.65 |
| Outstanding Shares | 31,793,739 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 21.68 |
|---|---|
| PEG | -23.75 |
| Price to Sales | 1.48 |
| Price to Book Ratio | 4.22 |
| Enterprise Value to Revenue | 2.6 |
| Enterprise Value to EBIT | 11.82 |
| Enterprise Value to Net Income | 39 |
| Total Debt to Enterprise | 0.5 |
| Debt to Equity | 3.68 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Collegium Pharmaceutical Inc
CEO: Joseph Ciaffoni